IL249705B - Influenza virus vaccines and uses thereof - Google Patents

Influenza virus vaccines and uses thereof

Info

Publication number
IL249705B
IL249705B IL249705A IL24970516A IL249705B IL 249705 B IL249705 B IL 249705B IL 249705 A IL249705 A IL 249705A IL 24970516 A IL24970516 A IL 24970516A IL 249705 B IL249705 B IL 249705B
Authority
IL
Israel
Prior art keywords
influenza virus
virus vaccines
vaccines
influenza
virus
Prior art date
Application number
IL249705A
Other languages
Hebrew (he)
Other versions
IL249705A0 (en
Inventor
Radosevic Katarina
Impagliazzo Antonietta
Wilem Meijberg Jan
Wagner Michelle
Ding Zhaoqing
Original Assignee
Janssen Vaccines & Prevention Bv
Radosevic Katarina
Impagliazzo Antonietta
Wilem Meijberg Jan
Wagner Michelle
Ding Zhaoqing
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2015/065663 external-priority patent/WO2016005482A1/en
Application filed by Janssen Vaccines & Prevention Bv, Radosevic Katarina, Impagliazzo Antonietta, Wilem Meijberg Jan, Wagner Michelle, Ding Zhaoqing filed Critical Janssen Vaccines & Prevention Bv
Publication of IL249705A0 publication Critical patent/IL249705A0/en
Publication of IL249705B publication Critical patent/IL249705B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
IL249705A 2014-07-10 2016-12-21 Influenza virus vaccines and uses thereof IL249705B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP14176459 2014-07-10
US201462062754P 2014-10-10 2014-10-10
EP14195143 2014-11-27
EP15155761 2015-02-19
PCT/EP2015/065663 WO2016005482A1 (en) 2014-07-10 2015-07-09 Influenza virus vaccines and uses thereof

Publications (2)

Publication Number Publication Date
IL249705A0 IL249705A0 (en) 2017-02-28
IL249705B true IL249705B (en) 2021-03-25

Family

ID=72801266

Family Applications (1)

Application Number Title Priority Date Filing Date
IL249705A IL249705B (en) 2014-07-10 2016-12-21 Influenza virus vaccines and uses thereof

Country Status (1)

Country Link
IL (1) IL249705B (en)

Also Published As

Publication number Publication date
IL249705A0 (en) 2017-02-28

Similar Documents

Publication Publication Date Title
ZA201700165B (en) Influenza virus vaccines and uses thereof
SG11201610443WA (en) Influenza virus vaccines and uses thereof
SG10201913630YA (en) Zika virus vaccine
SMT202200361T1 (en) Respiratory virus vaccines
IL286265A (en) Novel tilapia virus and uses thereof
HUE061679T2 (en) Zika virus vaccine
SG11201803474UA (en) Vaccines against hepatitis b virus
ZA201700952B (en) Indoles for use in influenza virus infection
EP3119883A4 (en) Influenza virus vectors and uses therefor
ZA201509229B (en) Influenza virus vaccines and uses thereof
AP2017009834A0 (en) Fmdv recombinant vaccines and uses thereof
GB201406608D0 (en) Virus
GB201613191D0 (en) Zika virus vaccine
SG11201702116VA (en) Viral rna segments as immunomodulatory agents and vaccine components
IL262731A (en) Therapeutic hpv vaccine combinations
SG11201701279VA (en) Alkylated influenza vaccines
IL247185B (en) Tilapia lake virus vaccines
GB201419572D0 (en) Virus
EP3240568A4 (en) Recombinant influenza virus vaccines for influenza and respiratory syncytial virus
EP3157950A4 (en) Influenza vaccines and methods of use thereof
IL249704A0 (en) Influenza virus vaccines and uses thereof
IL249705A0 (en) Influenza virus vaccines and uses thereof
HK1236965A1 (en) Influenza virus vaccines and uses thereof
PT3393510T (en) Zika virus vaccine
HK1259941A1 (en) Respiratory virus vaccines

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed